U.S. Intravenous Immunoglobulin Market Outlook for Autoimmune Diseases

The U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7